Myriam Fornage, Ph.D.

Myriam FORNAGE, Ph.D., studies the genetics and genomics of brain vascular disease and brain aging, both in its clinical and pre-clinical forms in well characterized and diverse populations from young adulthood to old age.

Dr. Fornage conducts large-scale genetic studies that have led to the identification of novel genes for brain vascular disease, brain aging and related MRI endophenotypes. She is an active investigator of several large national and international consortia including the Cohorts of Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium, the NHLBI Trans-Omics for Precision Medicine (TOPMed) Program and the National Institute of Aging Alzheimer’s Disease Sequencing Project (ADSP). She is a member of the Leadership Committee of the American Heart Association Council on Genomic and Precision Medicine and the Stroke Statistics Committee of the Epidemiology & Prevention Council, and has served on several National Institutes of Health expert advisory panels, including as a member of the Genetics of Health and Disease (GHD) study section.